Epigenome-based personalized medicine in human cancer

Epigenomics
Wenji YanMingzhou Guo

Abstract

Cancer genome sequencing has created an opportunity for precision medicine. Thus far, genetic alterations can only be used to guide treatment for small subsets of certain cancer types with these key alterations. Similar to mutations, epigenetic events are equally suitable for personalized medicine. DNA methylation alterations have been used to identify tumor-specific drug responsive markers. Methylation of MGMT sensitizes gliomas to alkylating agents is an example of epigenetic personalized medicine. Recent studies have revealed that 5-azacytidine and decitabine show activity in myelodysplasia, lung and other cancers. There are currently at least 20 kinds of histone deacetylase inhibitors in clinical testing. Inhibitors targeting other epigenetic regulators are being clinically tested, such as EZH2 inhibitor EPZ-6438.

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Aug 10, 2000·Nature·D M Scolnick, T D Halazonetis
Nov 9, 2000·The New England Journal of Medicine·M EstellerJ G Herman
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A YouS L Schreiber
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Daiya Takai, Peter A Jones
Apr 15, 2003·Nature Medicine·Toshiyasu TaniguchiAlan D D'Andrea
Jan 20, 2004·Molecular and Cellular Biology·Jonathan C ChengPeter A Jones
Apr 2, 2004·Nature Reviews. Cancer·Stanton L Gerson
Oct 7, 2004·Trends in Molecular Medicine·Jay L Hess
Feb 24, 2005·Journal of the American Chemical Society·Lei ZengMing-Ming Zhou
Nov 2, 2005·Nature Reviews. Molecular Cell Biology·Cyrus Martin, Yi Zhang
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·José Luis RamirezUNKNOWN Spanish Lung Cancer Group
Jun 24, 2006·Chemistry & Biology·Min Gyu LeeRamin Shiekhattar
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mingzhou GuoJames G Herman
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Sep 21, 2006·Nature Reviews. Genetics·Robert J KloseYi Zhang
Feb 24, 2007·Nature Reviews. Cancer·Sreenath V SharmaDaniel A Haber
Aug 19, 2007·Nature Methods·Margaret S EbertPhillip A Sharp
Nov 7, 2007·Nature Structural & Molecular Biology·Sabbi Lall
Aug 30, 2008·Mutation Research·Jeffrey A Simon, Carol A Lange
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fadi BraitehRazelle Kurzrock
Dec 23, 2008·Epigenetics : Official Journal of the DNA Methylation Society·Mingzhou GuoHetty E Carraway
Jan 30, 2009·Journal of Cellular and Molecular Medicine·Anna M Krichevsky, Galina Gabriely
Feb 13, 2009·Nature·Axel ViselLen A Pennacchio

❮ Previous
Next ❯

Citations

Jan 4, 2017·Nucleosides, Nucleotides & Nucleic Acids·Robert Van OstrandAhmed M Awad
Feb 2, 2017·Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'oto-rhino-laryngologie Et De Chirurgie Cervico-faciale·Cameron LindsayVincent L Biron
Jul 4, 2017·International Journal of Molecular Sciences·Tomas EckschlagerJan Hrabeta
Mar 13, 2018·Expert Opinion on Therapeutic Targets·Karolina Nemes, Michael C Frühwald
Dec 2, 2017·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Shao-Shan C Huang, Joseph R Ecker
Jan 10, 2019·Experimental Dermatology·Sangjo KangTudorita Tumbar
Jul 25, 2019·Lab on a Chip·Chengyu DengChang Lu
Oct 22, 2016·Medical & Biological Engineering & Computing·Xiaoran DuanYongjun Wu
Jul 12, 2018·Nucleic Acids Research·Ying-Ying LeeAlfred S L Cheng
Nov 7, 2019·Biomarker Research·Mingzhou GuoJames G Herman
Oct 24, 2018·Clinical Epigenetics·Yu ZhengLili Yang
Dec 24, 2019·Frontiers in Pharmacology·Chao Yu, Shougang Zhuang
Sep 26, 2020·Biomarker Research·Aiai Gao, Mingzhou Guo
Jul 25, 2020·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Jessica Y HsuRushita A Bagchi
Aug 3, 2019·Progress in Retinal and Eye Research·Michael PowerFrançois Paquet-Durand
Jun 14, 2020·Joint, Bone, Spine : Revue Du Rhumatisme·Bilade CherqaouiFélicie Costantino
Jun 9, 2021·Journal of Medicinal Chemistry·Krimo ToutahPatrick T Gunning
Apr 23, 2020·Journal of Medicinal Chemistry·Tingting LiuGuiyun Duan

❮ Previous
Next ❯

Methods Mentioned

BETA
methylation profiling
ubiquitination
acetylation
xenografts
histone acetylation
xenograft

Clinical Trials Mentioned

NCT02034123
NCT01587703

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Hidenori Nakajima
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Rolf I SkotheimOla Myklebost
Epigenomics
Michael T McCabe, Caretha L Creasy
© 2021 Meta ULC. All rights reserved